SEC Form 4 · accession 0001562180-18-003853
G1 Therapeutics, Inc. · GTHX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth Rudnick
Director
Period of report
Sep 4, 2018
Accepted (ET)
Sep 6, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2018 | M | 10,000 | $0.39 | A | 10,000 | D | |
| Common StockF2 | Sep 4, 2018 | S | 9,500 | $59.9293 | D | 500 | D | |
| Common Stock | Sep 4, 2018 | S | 500 | $60.31 | D | 0 | D | |
| Common StockF3 | holding | — | — | — | 58,282 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $0.39 | Sep 4, 2018 | M | 10,000 | D | — | Jan 21, 2024 | Common Stock | 10,000 | 20,607 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- F2The price represents the weighted average price with a low of $59.31 and a high of $60.23. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- F3These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F4All shares underlying this option have vested.